C07K 16/26
Against hormones
Official title: against hormones {; against hormone releasing or inhibiting factors}
C07K16/26 (Against hormones) appears on 913 US grants and 1,225 published applications in this corpus.
Search patents in C07K- Granted patents
- 913
- Published applications
- 1,225
- Assignees
- 628
- Inventors
- 2,304
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 0 | 0 |
| 1978 | 6 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 6 | 0 |
| 1991 | 6 | 0 |
| 1992 | 12 | 0 |
| 1993 | 18 | 0 |
| 1994 | 15 | 0 |
| 1995 | 9 | 0 |
| 1996 | 13 | 0 |
| 1997 | 22 | 0 |
| 1998 | 32 | 0 |
| 1999 | 25 | 0 |
| 2000 | 20 | 0 |
| 2001 | 25 | 8 |
| 2002 | 16 | 29 |
| 2003 | 14 | 34 |
| 2004 | 14 | 37 |
| 2005 | 10 | 45 |
| 2006 | 17 | 38 |
| 2007 | 13 | 48 |
| 2008 | 15 | 50 |
| 2009 | 16 | 52 |
| 2010 | 33 | 48 |
| 2011 | 37 | 45 |
| 2012 | 23 | 40 |
| 2013 | 31 | 45 |
| 2014 | 29 | 53 |
| 2015 | 29 | 60 |
| 2016 | 43 | 61 |
| 2017 | 36 | 64 |
| 2018 | 32 | 50 |
| 2019 | 49 | 76 |
| 2020 | 47 | 59 |
| 2021 | 35 | 63 |
| 2022 | 28 | 51 |
| 2023 | 29 | 46 |
| 2024 | 21 | 41 |
| 2025 | 26 | 41 |
| 2026 | 16 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Monoclonal antibody and polyclonal antibody and oxytocin quantification method based on same29 Sep 2026US 12,748,117 B2Universidad De Murcia
- GLP1R agonist NMDAR antagonist conjugates22 Sep 2026US 12,742,006 B2Københavns Universitet
- Parathyroid hormone receptor 1(PTH1R) antibodies and uses thereof4 Aug 2026US 12,698,346 B2Xoma (US) LLC
- Oxyntomodulin binding molecules, and uses thereof14 Jul 2026US 12,679,889 B2Eli Lilly and Company
- High concentration formulations for monoclonal antibodies8 Oct 2026US 2026/0308252 A1Icahn School of Medicine at Mount Sinai
- Anxiolytic therapy8 Oct 2026US 2026/0308253 A1
- Methods and means for the production of ig-like molecules8 Oct 2026US 2026/0308655 A1Merus N.V.
- Compositions and methods for treating diseases and conditions associated with activation of the nlrp3 inflammasome1 Oct 2026US 2026/0297180 A1
- Engineered antibody fusion proteins with modulable binding constants and their applications1 Oct 2026US 2026/0297181 A1The University of North Carolina at Chapel Hill
Most cited
By later US patents
- Methods for producing members of specific binding pairs893US 5,969,108 ACambridge Antibody Technology Limited · 1999
- Production of anti-self antibodies from antibody segment repertoires and displayed on phage541US 5,885,793 ACambridge Antibody Technology Limited · 1999
- Protein/(poly)peptide libraries350US 6,300,064 B1Morphosys AG · 2001
- Production of anti-self bodies from antibody segment repertories and displayed on phage229US 6,582,915 B1Cambridge Antibody Technology Limited · 2003
- Production of anti-self antibodies from antibody segment repertoires and displayed on phage228US 6,593,081 B1Cambridge Antibody Technology Limited · 2003